Eben Tessari
Founder at KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
Net worth: 2 M $ as of 2024-06-29
Profile
Eben P.
Tessari is the founder.
He founded Kiniksa Pharmaceuticals Ltd.
in 2015, where he holds the title of Chief Operating Officer & Senior Vice President.
Currently, Mr. Tessari is the Chief Operating Officer & Senior Vice President at Kiniksa Pharmaceuticals International Plc, starting in 2024.
In his former positions, Mr. Tessari was the Director-Business & Corporate Development at Civitas Therapeutics, Inc. from 2013 to 2014, and the Senior Director & Head-Business Development at Synageva BioPharma Corp.
from 2014 to 2015.
Mr. Tessari obtained his graduate degree from Boston University and Suffolk University, and his undergraduate degree from Northeastern University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.31% | 2024-04-14 | 126,024 ( 0.31% ) | 2 M $ | 2024-06-29 |
Eben Tessari active positions
| Companies | Position | Start |
|---|---|---|
| KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC | Founder | 2015-06-30 |
Former positions of Eben Tessari
| Companies | Position | End |
|---|---|---|
| SYNAGEVA BIOPHARMA CORP | Corporate Officer/Principal | 2015-06-30 |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Corporate Officer/Principal | 2014-11-30 |
Training of Eben Tessari
| Northeastern University | Undergraduate Degree |
| Boston University | Graduate Degree |
| Suffolk University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Kiniksa Pharmaceuticals International Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Its products include Rilonacept, Mavrilimumab, Vixarelimab, and KPL-404. The company was founded by Sanj K. Patel, Stephen Frank Mahoney, Krisha S. Mahoney, Thomas W. Beetham, Christopher Heberlig, Carsten Boess, Rasmus Holm-Jorgensen, Gregory Alex Grabowksi, Aaron Isadore Young, Eben P. Tessari, Jennifer Lynne Mason and Mickenzie Elizabeth Gallagher in July 2015 and is headquartered in Lexington, MA. | Health Technology |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Synageva BioPharma Corp. is a biopharmaceutical company which focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and high unmet medical need. The company is currently evaluating sebelipase alfa in global clinical trials for LAL Deficiency, a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults, and in infants, premature death often before six months of age. Synageva BioPharma was founded in 1993 and is headquartered in Lexington, MA. | Health Technology |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Health Technology |
- Stock Market
- Insiders
- Eben Tessari
